EAM Investors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98M | Buy |
71,971
+2,790
| +4% | +$154K | 0.6% | 79 |
|
|
2025
Q1 | $3.35M | Buy |
+69,181
| New | +$3.35M | 0.58% | 77 |
|
|
2023
Q3 | – | Sell |
-87,953
| Closed | -$2.43M | – | 361 |
|
|
2023
Q2 | $2.43M | Buy |
+87,953
| New | +$2.43M | 0.45% | 80 |
|
|
2021
Q3 | – | Sell |
-101,019
| Closed | -$4.53M | – | 368 |
|
|
2021
Q2 | $4.53M | Buy |
+101,019
| New | +$4.53M | 0.7% | 10 |
|
|
2021
Q1 | – | Sell |
-44,067
| Closed | -$888K | – | 422 |
|
|
2020
Q4 | $888K | Sell |
44,067
-30,279
| -41% | -$610K | 0.15% | 277 |
|
|
2020
Q3 | $1.45M | Buy |
+74,346
| New | +$1.45M | 0.34% | 118 |
|